H5N1感染(トリインフルエンザ)(H5N1 Infection (Avian Influenza)):世界の治験レビュー(2014年下半期版)

◆英語タイトル:H5N1 Infection (Avian Influenza) Global Clinical Trials Review, H2, 2014
◆商品コード:GDHC2447CTIDB
◆発行会社(リサーチ会社):GlobalData
◆発行日:2014年11月30日
◆ページ数:79
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single UserUSD2,500 ⇒換算¥260,000見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD5,000 ⇒換算¥520,000見積依頼/購入/質問フォーム
Global Site License(複数国内共有可)USD7,500 ⇒換算¥780,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

当調査レポートでは、世界におけるH5N1感染(トリインフルエンザ)(H5N1 Infection (Avian Influenza)) 治療の臨床試験動向について調査・分析し、アジア太平洋/欧州/北米/中南米の主要国における治験件数、段階(フェーズ)別の治験件数、進捗状況別の治験件数、治験目標の達成状況、有望な薬剤、治験関連の最新ニュース、代表的な企業・大学・研究機関における治験概要、代表的な治験のプロファイルなどのデータをまとめてお届けいたします。

・イントロダクション
  - H5N1感染(トリインフルエンザ)(H5N1 Infection (Avian Influenza))
  - 当レポートの概要
・H5N1感染(トリインフルエンザ)(H5N1 Infection (Avian Influenza)):各地域別治験状況
  - 各国の治験件数及び平均被験者数
   アジア太平洋の主要国における治験件数
   欧州の主要国における治験件数
   北米の主要国における治験件数
   中東・アフリカの主要国における治験件数
   中南米の主要国における治験件数
・G7諸国での治験件数
・G7諸国での治験件数:段階別
・G7諸国での治験件数:進捗状況別
・段階(フェーズ)別の治験件数:進行中の治験(段階別)
・進捗状況別の治験件数
・治験目標の達成状況
・未完了の治験件数
・一定期間に採用された被験者
・スポンサーの種類別治験件数
・有望なスポンサー
・有望な薬剤
・治験のプロファイル
  - 代表的な企業における治験概要
  - 代表的な大学・研究機関における治験概要
・5つの代表的な治験のプロファイル
【レポートの概要】

H5N1 Infection (Avian Influenza) Global Clinical Trials Review, H2, 2014

Summary

GlobalData’s clinical trial report, “H5N1 Infection (Avian Influenza) Global Clinical Trials Review, H2, 2014″ provides data on the H5N1 Infection (Avian Influenza) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on H5N1 Infection (Avian Influenza). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating H5N1 Infection (Avian Influenza). This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
H5N1 Infection (Avian Influenza) 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Clinical Trials by G7 Countries: Proportion of H5N1 Infection (Avian Influenza) to Infectious Disease Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by E7 Countries: Proportion of H5N1 Infection (Avian Influenza) to Infectious Disease Clinical Trials 17
Clinical Trials by Phase in E7 Countries 18
Clinical Trials in E7 Countries by Trial Status 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Clinical Trials by End Point Status 23
Unaccomplished Trials of H5N1 Infection (Avian Influenza) 24
Subjects Recruited Over a Period of Time 25
Clinical Trials by Sponsor Type 26
Prominent Sponsors 27
Top Companies Participating in H5N1 Infection (Avian Influenza) Therapeutics Clinical Trials 28
Prominent Drugs 29
Latest Clinical Trials News on H5N1 Infection (Avian Influenza) 30
Oct 07, 2014: Candidate H7N9 Avian Flu Vaccine Works Better with Adjuvant 30
Clinical Trial Profiles 31
Clinical Trial Overview of Top Companies 31
Novartis AG 31
Clinical Trial Overview of Novartis AG 31
GlaxoSmithKline plc 32
Clinical Trial Overview of GlaxoSmithKline plc 32
Baxter International Inc. 33
Clinical Trial Overview of Baxter International Inc. 33
Mitsubishi Tanabe Pharma Corporation 34
Clinical Trial Overview of Mitsubishi Tanabe Pharma Corporation 34
AstraZeneca PLC 35
Clinical Trial Overview of AstraZeneca PLC 35
Microgen Scientific Industrial Company for Immunobiological Medicines 36
Clinical Trial Overview of Microgen Scientific Industrial Company for Immunobiological Medicines 36
Green Cross Holdings Corporation 37
Clinical Trial Overview of Green Cross Holdings Corporation 37
Generex Biotechnology Corporation 38
Clinical Trial Overview of Generex Biotechnology Corporation 38
Daiichi Sankyo Company, Limited 39
Clinical Trial Overview of Daiichi Sankyo Company, Limited 39
CSL Limited 40
Clinical Trial Overview of CSL Limited 40
Clinical Trial Overview of Top Institutes / Government 41
The National Institute of Allergy and Infectious Diseases 41
Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases 41
Mahidol University 42
Clinical Trial Overview of Mahidol University 42
National Hospital Organization Mie National Hospital 43
Clinical Trial Overview of National Hospital Organization Mie National Hospital 43
The Chemo-Sero-Therapeutic Research Institute 44
Clinical Trial Overview of The Chemo-Sero-Therapeutic Research Institute 44
Clinical Research Center, National Hospital Organization 45
Clinical Trial Overview of Clinical Research Center, National Hospital Organization 45
Queen Mary Hospital 46
Clinical Trial Overview of Queen Mary Hospital 46
Tohoku University Graduate School of Medicine, Department Of Surgery 47
Clinical Trial Overview of Tohoku University Graduate School of Medicine, Department Of Surgery 47
Fraunhofer Center for Molecular Biotechnology 48
Clinical Trial Overview of Fraunhofer Center for Molecular Biotechnology 48
South East Asia Infectious Disease Clinical Research Network 49
Clinical Trial Overview of South East Asia Infectious Disease Clinical Research Network 49
Five Key Clinical Profiles 50
Appendix 77
Abbreviations 77
Definitions 77
Research Methodology 78
Secondary Research 78
About GlobalData 79
Contact Us 79
Disclaimer 79
Source 79

List of Tables
H5N1 Infection (Avian Influenza) Therapeutics, Global, Clinical Trials by Region, 2014* 7
H5N1 Infection (Avian Influenza) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
H5N1 Infection (Avian Influenza) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
H5N1 Infection (Avian Influenza) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
H5N1 Infection (Avian Influenza) Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
H5N1 Infection (Avian Influenza) Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
H5N1 Infection (Avian Influenza) Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 13
Proportion of H5N1 Infection (Avian Influenza) to Infectious Disease Clinical Trials, G7 Countries (%), 2014* 14
H5N1 Infection (Avian Influenza) Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 15
H5N1 Infection (Avian Influenza) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 16
Proportion of H5N1 Infection (Avian Influenza) to Infectious Disease Clinical Trials, E7 Countries (%), 2014* 17
H5N1 Infection (Avian Influenza) Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 18
H5N1 Infection (Avian Influenza) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 19
H5N1 Infection (Avian Influenza) Therapeutics, Global, Clinical Trials by Phase, 2014* 20
H5N1 Infection (Avian Influenza) Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 21
H5N1 Infection (Avian Influenza) Therapeutics, Global, Clinical Trials by Trial Status, 2014* 22
H5N1 Infection (Avian Influenza) Therapeutics Clinical Trials, Global, by End Point Status, 2014* 23
H5N1 Infection (Avian Influenza) Therapeutics, Global, Terminated Clinical Trials, 2014* 24
H5N1 Infection (Avian Influenza) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 25
H5N1 Infection (Avian Influenza) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 26
H5N1 Infection (Avian Influenza) Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 27
H5N1 Infection (Avian Influenza) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 28
H5N1 Infection (Avian Influenza) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 29
H5N1 Infection (Avian Influenza) Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014* 31
H5N1 Infection (Avian Influenza) Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014* 32
H5N1 Infection (Avian Influenza) Therapeutics Clinical Trials Market, Global, Clinical Trials by Baxter International Inc., 2014* 33
H5N1 Infection (Avian Influenza) Therapeutics Clinical Trials Market, Global, Clinical Trials by Mitsubishi Tanabe Pharma Corporation, 2014* 34
H5N1 Infection (Avian Influenza) Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2014* 35
H5N1 Infection (Avian Influenza) Therapeutics Clinical Trials Market, Global, Clinical Trials by Microgen Scientific Industrial Company for Immunobiological Medicines, 2014* 36
H5N1 Infection (Avian Influenza) Therapeutics Clinical Trials Market, Global, Clinical Trials by Green Cross Holdings Corporation, 2014* 37
H5N1 Infection (Avian Influenza) Therapeutics Clinical Trials Market, Global, Clinical Trials by Generex Biotechnology Corporation, 2014* 38
H5N1 Infection (Avian Influenza) Therapeutics Clinical Trials Market, Global, Clinical Trials by Daiichi Sankyo Company, Limited, 2014* 39
H5N1 Infection (Avian Influenza) Therapeutics Clinical Trials Market, Global, Clinical Trials by CSL Limited, 2014* 40
H5N1 Infection (Avian Influenza) Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2014* 41
H5N1 Infection (Avian Influenza) Therapeutics Clinical Trials Market, Global, Clinical Trials by Mahidol University, 2014* 42
H5N1 Infection (Avian Influenza) Therapeutics Clinical Trials Market, Global, Clinical Trials by National Hospital Organization Mie National Hospital, 2014* 43
H5N1 Infection (Avian Influenza) Therapeutics Clinical Trials Market, Global, Clinical Trials by The Chemo-Sero-Therapeutic Research Institute, 2014* 44
H5N1 Infection (Avian Influenza) Therapeutics Clinical Trials Market, Global, Clinical Trials by Clinical Research Center, National Hospital Organization, 2014* 45
H5N1 Infection (Avian Influenza) Therapeutics Clinical Trials Market, Global, Clinical Trials by Queen Mary Hospital, 2014* 46
H5N1 Infection (Avian Influenza) Therapeutics Clinical Trials Market, Global, Clinical Trials by Tohoku University Graduate School of Medicine, Department Of Surgery, 2014* 47
H5N1 Infection (Avian Influenza) Therapeutics Clinical Trials Market, Global, Clinical Trials by Fraunhofer Center for Molecular Biotechnology, 2014* 48
H5N1 Infection (Avian Influenza) Therapeutics Clinical Trials Market, Global, Clinical Trials by South East Asia Infectious Disease Clinical Research Network, 2014* 49

List of Figures
H5N1 Infection (Avian Influenza) Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
H5N1 Infection (Avian Influenza) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
H5N1 Infection (Avian Influenza) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
H5N1 Infection (Avian Influenza) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10
H5N1 Infection (Avian Influenza) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
H5N1 Infection (Avian Influenza) Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
H5N1 Infection (Avian Influenza) Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014* 13
Proportion of H5N1 Infection (Avian Influenza) to Infectious Disease Clinical Trials, G7 Countries (%), 2014* 14
H5N1 Infection (Avian Influenza) Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 15
H5N1 Infection (Avian Influenza) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 16
Proportion of H5N1 Infection (Avian Influenza) to Infectious Disease Clinical Trials, E7 Countries (%), 2014* 17
H5N1 Infection (Avian Influenza) Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 18
H5N1 Infection (Avian Influenza) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 19
H5N1 Infection (Avian Influenza) Therapeutics, Global, Clinical Trials by Phase (%), 2014* 20
H5N1 Infection (Avian Influenza) Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 21
H5N1 Infection (Avian Influenza) Therapeutics, Global, Clinical Trials by Trial Status, 2014* 22
H5N1 Infection (Avian Influenza) Therapeutics Clinical Trials, Global, by End Point Status, 2014* 23
H5N1 Infection (Avian Influenza) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 25
H5N1 Infection (Avian Influenza) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 26
H5N1 Infection (Avian Influenza) Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 27
H5N1 Infection (Avian Influenza) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 28
H5N1 Infection (Avian Influenza) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 29
GlobalData Methodology 78

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[H5N1感染(トリインフルエンザ)(H5N1 Infection (Avian Influenza)):世界の治験レビュー(2014年下半期版)]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆